VJX-22711-56562
3 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 853 / AZ
- Registered
- 2022-11-02
- Relationship
- Child or adolescent in my care
- Guardian
- 7Z6-47457-41736
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-14
Dose 1 — Pfizer-BioNTech
-
2022-08-04
Dose 2 — Pfizer-BioNTech
-
2022-10-24
Dose 3 — Pfizer-BioNTech
-
2022-11-02
Registered in v-safe
- 2022-11-02
- 2022-11-07
-
2022-11-14
Survey response — day 21, dose 3, dependentMedDRA: Body temperature increased, Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: He had a runny nose and slightly elevated temperature a couple days last week, mild cold was over after a couple of days and is now back to normal.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-21
- 2022-11-28
- 2022-12-05
- 2023-01-23
- 2023-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-14 | Pfizer-BioNTech | No |
| 2 | 2022-08-04 | Pfizer-BioNTech | No |
| 3 | 2022-10-24 | Pfizer-BioNTech | No |
Free text
Release 12 — day 21, dose 3, dependent
Symptoms: He had a runny nose and slightly elevated temperature a couple days last week, mild cold was over after a couple of days and is now back to normal.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release